Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9269001rdf:typepubmed:Citationlld:pubmed
pubmed-article:9269001lifeskim:mentionsumls-concept:C0042798lld:lifeskim
pubmed-article:9269001lifeskim:mentionsumls-concept:C0020490lld:lifeskim
pubmed-article:9269001lifeskim:mentionsumls-concept:C1524003lld:lifeskim
pubmed-article:9269001pubmed:issue8lld:pubmed
pubmed-article:9269001pubmed:dateCreated1997-9-22lld:pubmed
pubmed-article:9269001pubmed:abstractTextThis article presents three cases of decreased vision due to acquired hyperopia, which were caused by a chalazion of the upper eyelid. Through manifest refraction and computerized corneal topographic analysis, acquired hyperopia associated with central corneal flattening was revealed. These findings were responsible for the blurred vision that was reversed by chalazion resolution or removal. Although not usually considered a risk factor for refractive disorders other than astigmatism, chalazia of the upper eyelid can present as a decrease in vision associated with reversible central corneal flattening and acquired hyperopia.lld:pubmed
pubmed-article:9269001pubmed:languageenglld:pubmed
pubmed-article:9269001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9269001pubmed:citationSubsetIMlld:pubmed
pubmed-article:9269001pubmed:statusMEDLINElld:pubmed
pubmed-article:9269001pubmed:monthAuglld:pubmed
pubmed-article:9269001pubmed:issn1082-3069lld:pubmed
pubmed-article:9269001pubmed:authorpubmed-author:CohenE JEJlld:pubmed
pubmed-article:9269001pubmed:authorpubmed-author:RapuanoC JCJlld:pubmed
pubmed-article:9269001pubmed:authorpubmed-author:Santa CruzC...lld:pubmed
pubmed-article:9269001pubmed:authorpubmed-author:CulottaTTlld:pubmed
pubmed-article:9269001pubmed:issnTypePrintlld:pubmed
pubmed-article:9269001pubmed:volume28lld:pubmed
pubmed-article:9269001pubmed:ownerNLMlld:pubmed
pubmed-article:9269001pubmed:authorsCompleteYlld:pubmed
pubmed-article:9269001pubmed:pagination683-4lld:pubmed
pubmed-article:9269001pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:meshHeadingpubmed-meshheading:9269001-...lld:pubmed
pubmed-article:9269001pubmed:year1997lld:pubmed
pubmed-article:9269001pubmed:articleTitleChalazion-induced hyperopia as a cause of decreased vision.lld:pubmed
pubmed-article:9269001pubmed:affiliationCornea Service, Wills Eye Hospital, Philadelphia, PA 19107, USA.lld:pubmed
pubmed-article:9269001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9269001pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9269001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9269001lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9269001lld:pubmed